OSTX
OS Therapies Incorporated
There isn't enough reported data to score OSTX yet.
OSTX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
OSTX's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
OSTX PE Valuation
OSTX has no meaningful PE right now: it lost money over the past year.
OSTX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect OSTX's losses to shrink, with revenue growing.
OSTX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.08 | -$0.22 |
| Q1 2026 | -$1.07 | -$0.14 |
| Q4 2025 | -$0.98 | -$0.10 |
| Q3 2025 | -$0.89 | -$0.25 |
| Q2 2025 | -$0.86 | -$0.30 |
| Q1 2025 | -$0.93 | -$0.62 |
| Q4 2024 | -$0.88 | -$0.70 |
| Q3 2024 | -$0.64 | -$0.54 |
OSTX lost $1.08 per share over the past year, a bigger loss than the year before.
OSTX Quarterly Revenue
OSTX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$3.7M | -$1.4M |
| Q1 2025 | -$3.4M | -$2.8M |
| Q4 2024 | -$2.4M | -$1.5M |
| Q1 2024 | -$641.7K | -$213.5K |
| Q4 2023 | -$871.1K | +$651.9K |
| Q1 2023 | -$428.2K | +$532.7K |
| Q4 2022 | -$1.5M | -$834.4K |
OSTX has burned cash in almost every quarter: −$14M over the past year, against −$3M the year before.
OSTX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +14% | +5.2M shares |
| 1 year | +107% | +22.7M shares |
| 3 years | +340% | +33.9M shares |
OSTX has 44M diluted shares, up 107% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
OSTX Net Leverage
OSTX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
OSTX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.6 | Oversold |
| Stochastic | 15.3 | Oversold |
OSTX's weekly RSI is 28 (oversold) and its Stochastic is 15 (oversold).
OSTX PE vs Healthcare Sector
OSTX has no meaningful PE right now: it lost money over the past year.
OSTX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.31 | 43% below |
| 20 week MA | $1.52 | 51% below |
| 50 week MA | $1.56 | 52% below |
| 100 week MA | $1.82 | 59% below |
OSTX is in a downtrend: it's below all four of its weekly moving averages, and 59% below its 100-week average.
OSTX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $4.00 | $5.16 | +29% |
| 2025 | $5.16 | $1.51 | -71% |
| 2026 YTD | $1.51 | $0.75 | -50% |
OSTX has finished lower in one of the last two years. It's down 50% so far in 2026.